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To date, bovine spongiform encephalopathy (BSE) and its human counterpart, variant Creutzfeldt-Jakob disease, have
been associated with a single prion strain. This strain is characterised by a unique and remarkably stable biochemical
profile of abnormal protease-resistant prion protein (PrP
res) isolated from brains of affected animals or humans.
However, alternate PrP
res signatures in cattle have recently been discovered through large-scale screening. To test
whether these also represent separate prion strains, we inoculated French cattle isolates characterised by a PrP
res of
higher apparent molecular mass—called H-type—into transgenic mice expressing bovine or ovine PrP. All mice
developed neurological symptoms and succumbed to these isolates, showing that these represent a novel strain of
infectious prions. Importantly, this agent exhibited strain-specific features clearly distinct from that of BSE agent
inoculated to the same mice, which were retained on further passage. Moreover, it also differed from all sheep scrapie
isolates passaged so far in ovine PrP-expressing mice. Our findings therefore raise the possibility that either various
prion strains may exist in cattle, or that the BSE agent has undergone divergent evolution in some animals.
Citation: Be ´ringue V, Bencsik A, Le Dur A, Reine F, Laı ¨ TL, et al. (2006) Isolation from cattle of a prion strain distinct from that causing bovine spongiform encephalopathy.
PLoS Pathog 2(10): e112. DOI: 10.1371/journal.ppat.0020112
Introduction
While transmissible spongiform encephalopathies (TSEs) in
small ruminants and humans are believed to involve distinct
prion strains [1,2], a single prion strain has been associated so
far with bovine spongiform encephalopathy (BSE) and its
human counterpart, variant Creutzfeldt-Jakob disease (vCJD)
[3–6]. In particular, the abnormal, protease-resistant form of
prion protein (PrP
res) that accumulates in the brains of
infected individuals [7] shows a consistently unique electro-
phoretic proﬁle in immunoblots [8]. However, the biochem-
ical testing of the brains of slaughtered and fallen cattle,
which was intensiﬁed since 2000 in European countries as a
means to protect the consumers, has led to the discovery of
positive samples that showed distinct PrP
res proﬁles. These
atypical proﬁles have been sorted into two groups so far,
provisionally termed H-type when the size of the protease
resistant fragments is higher than for BSE, and bovine
amyloidotic spongiform encephalopathy, or L-type, when it
is lower [9,10]. These observations raise the possibility that as
yet unrecognised prion strains may exist in cattle as in other
species [11], and have potential implications in terms of
public health. Unlike bovine amyloidotic spongiform ence-
phalopathy isolates, which derive from animals with deﬁned
histopathological abnormalities [10], precise information
corroborating a prion disease is lacking for H-type cases. It
was therefore crucial to determine through experimental
transmission whether such cases reﬂect some alteration in
PrP metabolism, possibly in aging animals, or involve a truly
infectious agent.
In this study, we report the transmission of a TSE-like
disease by inoculation of French cattle isolates identiﬁed as
H-type variants to two lines of PrP transgenic mice.
Furthermore, we provide compelling evidence that this agent
has unique features compared to epizootic BSE and other
related agents. We also establish that there is no link with
ovine TSE isolates transmitted so far to these models.
Results
H-Type Isolates Are Transmissible to Mice
Two transgenic mouse lines were used as recipient for
transmission experiments. The tg540 line is a newly estab-
lished line that expresses bovine PrP (Protocol S1), resulting
in an enhanced susceptibility to BSE agent compared to
conventional mice [6,12]. The tg338 line, expressing the VRQ
(Val
136Arg
154Gln
171) allele of ovine PrP, has allowed an
efﬁcient transmission of natural scrapie isolates from sheep
and goat [13,14]. The rationale for including tg338 mice in
this study was the possibility that characterisation of a prion
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facilitated on such mice, by comparison with the ovine
isolates transmitted so far. Tg540 (tgBov) and tg338 (tgOv)
mice overexpress PrP in the brain at similar levels (;8- to 10-
fold). Both lines have a normal lifespan, the same as PrP
0/0
mice on which the transgenes were introduced. H-type
isolates representative of a series of seven samples identiﬁed
in France were inoculated intracerebrally to tgBov and tgOv
mice (Table 1). Typical BSE agents from cattle and from other
species was inoculated to the same mice for the sake of
comparison. Remarkably, all H-type isolates induced a
neurological disease on primary transmission, with a 100%
attack rate in both mouse lines. The mean survival times
observed with cases no. 1 and no. 2 in tgBov mice, ;400 d,
appeared to be prolonged compared to those for cattle,
sheep, goat BSE, and human vCJD inocula, which ranged
from ;250 to 380 d. Such a discrepancy could reﬂect a lesser
infectivity of H-type samples, consistent with their compara-
tively lower PrP
res content [9]. Moreover, the survival time
was reduced by ;100 d on subpassage, approaching that for
BSE from cattle or other sources on secondary passage, or on
primary passage for inocula of presumably higher titre (i.e.,
producing no substantial reduction of survival time on
subpassage: BSE no. 3 and ARQ [Ala
136Arg
154Gln
171] no. 1).
Upon transmission to tgOv mice, the mean incubation period
produced by the four H-type cases was strikingly homoge-
neous (586–612 d), consistent with a potentially unique agent
(Table 1). This was comparable to or even shorter than the
incubation periods of epizootic BSE or related inocula on the
same mice (560–792 d). As illustrated in Figure 1, the relative
incubation periods observed on tgOv and tgBov mice
appeared to differ signiﬁcantly among the H-type and BSE-
type agents. In addition, the reduction in incubation period
observed upon secondary transmission of H-type (case no. 2)
on tgOv mice was signiﬁcantly less dramatic than that
observed for vCJD and sheep BSE inocula (Table 1). Overall,
these suggested that H-type and BSE might be different TSE
agents.
H-Type PrP
res Profile Is Preserved in Transgenic Mice
The brains of diseased mice were analysed by immunoblot-
ting for the accumulation of abnormal PrP. PrP
res was readily
detected in all mice tested since the ﬁrst passage, consistent
with the efﬁcient transmission observed in both lines (10/10
and 33/33 positive brains for tgBov and tgOv mice,
respectively). The PrP
res molecular proﬁle was fairly uniform
Table 1. Transmission of Bovine Molecular Variant Cases (H-Type) to Transgenic Mice Expressing Bovine or Ovine PrP
Isolate Case Number Passage Mean survival time, d 6 SEM (n/n0)
a
tgBov Mice tgOv Mice
H-type 1 First 414 6 10 (5/5) 612 6 26 (10/10)
Second 317 6 6 (8/8) ND
2 First 401 6 9 (5/5) 595 6 18 (8/8)
Second 296 6 3 (9/9) 319 6 10 (6/6)
3 First ND 607 6 12 (6/6)
5 First ND 586 6 15 (9/9)
BSE 1 First 377 6 22 (6/6) ND
3 First 298 6 7 (9/9) 704 6 36 (7/7)
Second 283 6 10 (5/5) NA
Sheep BSE
b ARQ 1 First 278 6 2 (6/6) 560 6 60 (5/5)
Second 263 6 6 (6/6) 178 6 2 (4/4)
ARQ 3 First 339 6 25 (5/5) ND
ARR 1 First 340 6 8 (7/7) ND
Goat BSE
c CH636 First 253 6 9 (6/6) 590 6 43 (4/4)
Second 291 6 27 (5/5) NA
Variant CJD NHBY0/0003 First 343 6 8 (5/5) 792 6 22 (6/6)
Second 293 6 11 (6/6) 195 6 9 (6/6)
Control Sheep brain First 793 6 26 (0/9) 835 6 15 (0/6)
NA, not available; ND, not done.
aIntracerebral inoculation with 2 mg brain tissue equivalent; n/n0: diseased/inoculated.
bExperimental cases.
cField case.
DOI: 10.1371/journal.ppat.0020112.t001
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Synopsis
Prions are unconventional agents of proteic nature that are formed
of abnormal conformations of the host-encoded prion protein (PrP).
They cause fatal neurodegenerative diseases in both animals and
humans, and can be transmitted between species as exemplified in
humans by the emergence of variant Creutzfeldt-Jakob disease
following the epidemic of bovine spongiform encephalopathy (BSE)
in the United Kingdom. Since diagnosis of prion infection is only
possible once the central nervous system has been invaded, brains
of slaughtered or fallen cattle are routinely screened in Europe to
protect the consumers from BSE. This has unexpectedly led to the
discovery of unprecedented PrP conformations that were distinct
from the single one associated so far with BSE or BSE-related
diseases. To precisely determine their etiology, the authors have
studied the transmissibility of these new conformations, termed H-
type, to transgenic mice expressing either bovine or ovine PrP. They
show that these cases are highly pathogenic for these mice. The
authors also demonstrate that they are not directly related to the
agent involved in the BSE epidemic, supporting the view for
isolation of a new prion strain from cattle, whose prevalence and
associated zoonotic risk should be carefully monitored in the future.among the isolates. Remarkably, like the BSE agent for which
the typical signature was conserved whatever the donor
species ( 3 brains analysed per combination), the H-type
agent essentially retained its biochemical phenotype upon
serial transmission to tgBov as well as to tgOv mice expressing
a heterologous PrP
C (Figure 2 and below). Compared to BSE
PrP
res, it was characterised by a signiﬁcantly higher apparent
molecular mass (difference measured for unglycosylated
species: 0.9 6 0.05 kDa and 0.7 6 0.06 kDa in tgBov and
tgOv mice, respectively) and the relative proportions of
glycoforms were essentially similar. A further difference was
the lack of detectable PrP
res in the spleen of H-type diseased
tgOv mice (three to ﬁve spleens tested per isolate), while this
accumulated at substantial levels after BSE or vCJD infection
(Figure 2B).
H-Type and Epizootic BSE Agents Exhibit Distinct
Neuropathological Features
We next examined the PrP
res targeting and the vacuola-
tion in the brain, which are known to exhibit a strain-
dependent variation [6,15,16]. This was performed on tgBov
mice since they express a PrP
C homologous to that of the
donors, including the number of octarepeats [17], thus
providing a relevant context for comparing H-type and
epizootic BSE isolates. H-type isolates showed a similar
distribution of PrP
res deposits on both primary and
Figure 1. Survival Time in Transgenic Mice Infected with H-Type and
BSE-Type Agents
Mean survival times (days 6 SEM) upon primary transmission are shown
for tgBov (grey circles) and tgOv (black diamonds) mice inoculated with
H-type cases, BSE, and related isolates (see Table 1). The intervals
between the incubation times on each line are significantly different for
H-type and BSE agents (p , 0.0002, Fisher test).
DOI: 10.1371/journal.ppat.0020112.g001
Figure 2. Western Blot Analysis of PrP
res in the Brains of Transgenic Mice Infected with H-Type or BSE-Type Agents
(A) Primary or secondary (lane 6) transmission to tgBov mice. BSE-type inocula include cattle BSE no. 3 (lanes 3 and 7), sheep BSE ARQ no. 1 and ARR no.
1 (lanes 8 and 9), goat BSE (lane 10), and vCJD (lane 11). The PrP
res profiles of both H-type and BSE agents in cattle (lanes 2 and 3) are essentially similar
to those in tgBov mice (lanes 4–11). Brain tissue equivalent loaded: 2.5 mg in lane 2; 0.15 mg in lane 3; 0.5 mg in lanes 4–12. MI, mock-infected brain;
MM, molecular markers.
(B) Primary transmission to tgOv mice. H-type agent shows a distinct PrP
res pattern in the brain (Br) compared to BSE agents (lane 9, BSE no. 3; lane 10,
goat BSE; lane 11, vCJD). Note the lack of PrP
res signal in the spleen (Sp) of H-type–infected mice (lane 7), unlike that in BSE-infected mice (lane 8). Brain
or spleen tissue equivalent loaded: 3 mg in lane 2; 0.15 mg in lane 3; 0.5 mg in lanes 4–6; 2 mg in lanes 7–12.
(C and D) Ratio of high- and low-molecular-mass PrP
res glycoforms in the brains of tgBov (C) and tgOv (D) mice following challenge with H-type or BSE
agents (data plotted as means 6 SEM). H-type isolates are represented as triangles (no. 1, blue; no. 2, orange; no. 3, pink; and no. 5, black) and BSE
agents as squares (BSE no. 3, red; sheep BSE ARQ no. 1, grey; sheep BSE ARR no. 1, yellow; goat BSE, brown; and vCJD, light blue). Secondary
transmissions are represented by unfilled symbols of the same colour. Note the strikingly distinct glycoform ratio between H-type and BSE groups in
both mouse lines, as reported in cattle [9].
DOI: 10.1371/journal.ppat.0020112.g002
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Novel Prion Strain Isolated from Cattlesecondary transmission, as assessed by histoblotting on brain
coronal sections (Figure 3A–3B). The staining did not differ
from that seen with cattle BSE in several regions, such as the
striatum and several nuclei of the thalamus, including the
geniculate, ventral postero-lateral and -medial as well as the
brain stem (Figure 3A–3C and data not shown). However,
other areas such as the cerebral cortex, the corpus callosum
including the cingulum, the dorsal commissure, the alveus,
and ﬁmbria of the hippocampus were predominantly
stained with H-type, whereas BSE PrP
res was rather conﬁned
in the stratum oriens of the hippocampus (Figure 3A–3C).
Moreover, the overall intensity and aspect of PrP deposition
markedly differed between the two types of agents. While
immunochemistry revealed various types of PrP deposits in
both cases, thin diffuse PrP deposits were predominant in
H-type–infected brains, whereas the most frequent type was
granular in BSE-infected mouse brains. In several areas,
including the striatum and the substantia nigra (Figure 3D–
3G), there was a striking lack of correlation between the
intensity of PrP deposition and the severity of the
vacuolation. Overall, the vacuolation was much more intense
in the case of H-type variant (Figures 3 and 4): areas such as
the septum, hypothalamus, hippocampus, and cortex showed
severe spongiosis, accompanied by a pronounced reactive
glial astrocytosis based on GFAP staining (not shown), while
BSE-induced vacuolation was moderate in the same areas.
H-Type Agent Is Distinct from the Ovine TSE Isolates
Transmitted so Far to tgOv Mice
We ﬁnally examined whether H-type isolates may have an
ovine TSE origin. The majority of typical and atypical sheep
scrapie isolates we have studied so far transmits before a year
to tgOv mice ([13,14] and our unpublished data). Only a
group of sheep scrapie isolates from Italy (SSit) was found to
infect tgOv mice after a prolonged survival time within the
range of H-type cases. Indeed three of them, SSit cases no. 5,
no. 7, and no. 8, induced a typical neurodegenerative disease
with a mean survival time of 698 6 20 d (5/5 animals affected),
659 6 31 d (7/7), and 569 6 37 d (4/4), respectively. Case no. 5
incubation time was still longer than H-type case no. 2 on
subpassage (417 6 20 d, 6/6 animals affected). The PrP
res
molecular proﬁle observed in the brain of SSit-diseased mice
Figure 3. Regional Distribution of PrP
res and Vacuolar Changes in the Brains of Bovine Transgenic Mice Infected with H-Type or BSE Agents
Histoblots of representative coronal sections of tgBov mouse brains at the levels of the hippocampus are shown. The distribution of PrP
res deposits was
similar among H-type isolates (A) (B), and different from that of cattle BSE (C) in several areas indicated by arrowheads, such as the cortex, the corpus
callosum and dorsal commissure, alveus, fimbria, and stratum oriens of the hippocampus. Note that intensity of PrP deposition markedly differed
between H-type and BSE agents. Illustration of how this appears by immunohistochemistry in the striatum (D) (E) and substantia nigra (F) (G), H-type–
infected mice being less intensively labelled than those infected with BSE agent. By contrast, spongiosis was much more severe in H-type–infected
brains. Bars: 30 lm; insert: 7 lm.
DOI: 10.1371/journal.ppat.0020112.g003
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Novel Prion Strain Isolated from Cattle(more than four brains analysed per isolate) was characterised
by a signiﬁcantly higher apparent molecular mass (difference
of 0.7 6 0.2 kDa) and a slightly higher proportion of
diglycosylated PrP
res as compared with H-type–derived PrP
res
(Figure 5A–5C). These features were conserved on secondary
transmission (Figure 5A–5C). Another difference was again
the pronounced accumulation of SSit-associated PrP
res in the
spleen, while this was still impaired in H-type–infected mice,
even after two passages (three to ﬁve spleens tested per
combination; Figures 2B and 5A).
We then compared by histoblot distribution and nature of
PrP
res deposits within the brains of tgOv mice infected with a
second passage of H-type (no. 2) and SSit (no. 5) cases. Both
markedly differed between the two agents as illustrated in
Figure 5. Indeed, large plaques of SSit-associated PrP
res were
present in the pretectal nuclei and in related structures of the
limbic system such the fornix, the alveus, ﬁmbria, and
subiculum of the hippocampus. H-type–associated PrP
res
was detected instead in the corpus callosum, cortex, and
ventromedial thalamic nuclei (Figure 5D and unpublished
data). The deposits seem rather thin or granular. SSit case no.
8, which gave the shortest incubation period in tgOv mice,
was also inoculated by intracerebral route to tgBov mice. Of
note, no disease has been observed yet in mice monitored up
to 600 d after infection. In conclusion, these data suggest that
the H-type agent is unrelated to the ovine TSE isolates
transmitted so far to our transgenic lines.
Discussion
In this study we show that cattle brain samples positive for
abnormal PrP with a distinct molecular pattern, called H-
type, consistently produces a fatal, TSE-like disease upon
inoculation to both bovine and ovine PrP transgenic mice.
These results, corroborating the recent transmission to wild-
type mice [18], formally establish that such cases involve an
authentic TSE infectious agent. Importantly, we provide
detailed evidence that this newly recognised agent differs
from epizootic BSE agent derived from cattle or other
species.
Both molecular and biological criteria support the con-
clusion that H-type and BSE agents are distinct prion strains.
First, the incubation periods upon transmission to mice
expressing either bovine or ovine PrP produced different
patterns. Thus, while primary transmission to tgOv mice led
to longer survival times for both agents, the increase relative
to tgBov mice was signiﬁcantly less for H-type than for BSE-
type agents (Figure 1). Second, the molecular proﬁles of the
PrP
res fragments detected in the brain of diseased mice were
clearly distinguishable in either line. Strikingly, differences
observed in terms of fragment size and glycoform ratio were
essentially the same as in cattle brain. Third, unlike that for
BSE agents, no PrP
res signal could be seen in the spleen of H-
type–infected tgOv mice, indicative of a stronger neuro-
tropism at least in this host. Fourth, histopathological
examination of tgBov mice revealed a contrasting picture.
Typically, severe spongiosis and diffuse PrP deposition were
present in several areas of H-type–infected brains, while the
same areas of BSE-infected brains showed limited spongiosis
together with marked PrP deposition. Such discrepancies are
unlikely to result from unequal survival times since they were
also observed on secondary passage, where the two agents had
comparable incubation duration (unpublished data).
The isolation from cattle of a prion strain distinct from the
one implicated in the BSE epidemics raises several concerns.
One is whether H-type isolates might result from an exposure
to prions of small ruminants via alimentary or environmental
sources, since cattle have been shown to be susceptible to
experimental infection by sheep scrapie agent [19]. In this
regards, the better compatibility between ovine PrP sequence
and H-type as compared to BSE was intriguing (Figure 1).
However, our investigations do not support this. Among the
ﬁve groups of natural isolates we have identiﬁed so far in
tgOv mice ([13,14] and our unpublished data), only one
group, made up mostly of SSit isolates, proposed to be of
iatrogenic origin [20], showed an incubation time as
prolonged as for H-type cases. However, the PrP
res molecular
proﬁle, nature of deposits, and distribution within the brain
as well as the differential accumulation in the spleen strongly
distinguish H-type and SSit isolates. In addition, the latter
failed so far to transmit to tgBov mice.
H-type and BSE agents might be related despite their
distinguishable phenotypes. The isolation of an additional
strain upon exposure of transgenic or wild-type mice to the
epizootic BSE agent has been reported [21], thus questioning
its strain homogeneity. Also, molecular typing studies have
revealed the presence of a minor, non–BSE-type PrP
res
component in BSE- and vCJD-infected brains [22]. Hence,
H-type isolates could arise from the preferential ampliﬁca-
tion in certain individuals of a subcomponent present in BSE
Figure 4. Lesion Profiles in tgBov Mice Infected with H-Type or BSE
Agents
Mean scores (6 SEM) reflecting the intensity of vacuolation are shown
for H-type (no. 1 and no. 3, triangles) and BSE (no. 1 and no. 3, squares).
The nine grey-matter areas used to construct the profile are as follows:
dorsal medulla (1); cerebellar cortex (2); superior colliculus (3);
hypothalamus (4); medial thalamus (5); hippocampus (6); septum (7);
medial cerebral cortex at the level of the thalamus (8); and medial
cerebral cortex at the level of the septum (9).
DOI: 10.1371/journal.ppat.0020112.g004
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variant prions identiﬁed in mice might be informative in
that respect.
Alternatively, such unusual cases could reﬂect the existence
of a natural, sporadic disease in cattle. Although it is unclear
yet if such infections may lead to a clinical disease in the
natural host, they seem to occur at a low frequency, which is
reminiscent of the situation known for sporadic CJD in
humans [23,24]. Of note, the disparities between intensity of
PrP deposition and severity of vacuolation in the brains of H-
type–inoculated tgBov mice have also been observed with
sporadic CJD both in human or mouse infected brains [21,25].
These data, however, need to be consolidated through further
investigations, including epidemiological analysis. Indeed, an
implication of this latter scenario is that such bovine
‘‘atypical’’ cases could occur in countries free of BSE
exposure. The acquisition of novel properties by an endog-
enous, sporadic cattle TSE agent, as occasioned on passage
through an intermediary host or a physicochemical treatment
such as that applied to carcass-derived products, has been
invoked as one possible origin for the emergence of BSE
epidemics [7]. With the isolation of such agents, we can now
address this issue experimentally.
In conclusion, our ﬁndings support the view that at least
two and potentially three [10] distinct prion strains may be
present in cattle. The current uncertainties regarding the
origin, prevalence, and potential risk for humans of a strain
of TSE agent unrecognised until recently should support
continued efforts to characterise it in vivo and uphold the
surveillance exerted on cattle.
Materials and Methods
Isolates. The H-type [9], goat BSE (CH636 case [26]), and
experimental sheep BSE samples [27] were provided by the French
TSE Reference Laboratory (Agence Franc ¸aise de Se ´curite ´ Sanitaire
des Aliments [AFSSA], Lyon, France). The samples from French BSE
cases and from experimental sheep BSE (ARR [Ala
136Arg
154Arg
171]
genotype [28]) were provided by the Institut National de la Recherche
Agronomique (INRA; Toulouse, France) and the Institute for Animal
Figure 5. Comparison of H-Type and SSit Isolate Features upon Transmission to tgOv Mice
(A and B) Western blot analysis of PrP
res in the brains and spleens of tgOv mice infected with H-type or SSit isolates at first (lanes 2–4) and second
passage (lanes 5–11). H-type PrP
res shows a distinct pattern in the brain (Br) compared to SSit. The apparent molecular mass of SSit PrP
res is higher than
that of H-type or sheep BSE (shBSE), as shown after PNGase treatment (B). Note also that PrP
res is detected in the spleen (Sp) of SSit- but not of H-type–
infected mice. Tissue equivalent loaded: 1.5 mg in lanes 2–4; 0.04 mg in lane 5; 0.5 mg in lanes 6–7; 2 mg in lane 8; 0.01 mg in lane 9; 0.1 mg in lanes 10–
11. MM, molecular markers.
(C) Ratio of high- and low-molecular-mass PrP
res glycoforms in the brain of tgOv mice infected with H-type or SSit isolates (data plotted as mean 6
SEM). One H-type isolate (no. 2) is represented as orange triangle. SSit isolates are represented as circles (SSit no. 5, red; no. 7, brown; no. 8, yellow).
Secondary transmissions are represented by unfilled symbols of the same colour. Note the stably distinct glycoform ratios between H-type and SSit
agents upon serial passage.
(D) Regional distribution of PrP
res in the brain of tgOv mice infected with H-type or SSit isolates. Histoblots of representative coronal sections of tgOv
mouse brains at the levels of the hippocampus are shown. The distribution of H-type–associated PrP
res deposits was different from that of SSit in
regions such as the alveus of the hippocampus, the corpus callosum, the pretectal nuclei, the cortex, and the ventromedial thalamus. Note that the size
of PrP
res deposits markedly differed between the two types of isolates.
DOI: 10.1371/journal.ppat.0020112.g005
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respectively. The vCJD isolate was a World Health Organization
(WHO) reference sample from the National Institute for Biological
Standards and Control (NIBSC; Potters Bar, United Kingdom). SSit
isolates were provided by the Instituto Superiore di Sanita (ISS;
Rome, Italy).
Transgenic mice and transmission assays. The tg540 line expresses
the bovine PrP allele with 6 octarepeats under the control of the
cytomegalovirus (CMV) promoter on a FVB mouse line with PrP
0/0
background (Protocol S1). The tg338 line expresses the V136R154Q171
alleleofovinePrPatahomozygousstate,onamousePrP
0/0background
[29]. The transgene construct (tg3) consists in a bacterial artiﬁcial
chromosome(BAC)insertof125kbofsheepDNA[13].Allexperiments
were performed according to national guidelines. Each inoculum was
prepared extemporaneously in a class II microbiological cabinet using
disposable equipment. Individually identiﬁed 6- to 10-wk-old mice
were inoculated intracerebrally with 20 ll of a 10% (wt/vol) brain
homogenate in 5% glucose. Mice were monitored daily once ill and
killed in extremis.
Analysis of PrP
res molecular pattern. All procedures regarding
puriﬁcation and detection of PrP
res from brains and spleens of
infected mice were as described [14]. ICSM18 [30] or Sha31 [31] anti-
PrP antibodies were used. Enzymatic deglycosylation was performed
on denatured PrP
res with 1,000 U of recombinant PNGase (New
England Biolabs, Beverly, Massachusetts, United States) for 2 h at 37
8C in 1% Nonidet P40 and the proprietary buffer as described [30].
Determination of glycoform ratio and apparent molecular mass was
performed with the GeneTools software after acquisition of
chemiluminescent signals with a GeneGnome digital imager (Syn-
gene, Frederick, Maryland, United States).
Histopathology. For histoblot analysis [32], brains were rapidly
removed from killed mice and frozen on dry ice. Thick 10-lm
cryostat sections were cut, transferred onto Superfrost slides, and
kept at 20 8C until use. The procedure was performed as described
[14] using the 12F10 anti-PrP antibody [33]. All immunohistochem-
istry procedures regarding tissue processing have been described
previously [34]. Samples were ﬁxed in neutral-buffered 10% formalin
(4% formaldehyde) before parafﬁn embedding. After deparafﬁnisa-
tion, 6-lm-thick tissue sections were stained with haematoxylin/eosin.
Vacuolation proﬁles were established, following the standard method
described by Fraser and Dickinson [15], by using two to three brains
per isolate.
Supporting Information
Protocol S1. Description of the Bovine PrP Transgenic Mice (tg540
Line)
Found at DOI: 10.1371/journal.ppat.0020112.sd001 (92 KB DOC).
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) accession num-
bers for the genes and gene products discussed in this paper are
bovine PrP (NM181015) and sheep PrP (M31313).
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